Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2026-02-23 @ 6:24 AM
Study NCT ID:
NCT04038359
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2019-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma
Sponsor:
SecuraBio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-24
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-10
First Submit QC Date:
None
Study First Post Date:
2019-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-24
Results First Submit QC Date:
None
Results First Post Date:
2024-09-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-04
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL